英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
Desiderated查看 Desiderated 在百度字典中的解释百度英翻中〔查看〕
Desiderated查看 Desiderated 在Google字典中的解释Google英翻中〔查看〕
Desiderated查看 Desiderated 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Background and definition of the decision problem - KRAS mutation . . .
    The cobas KRAS Mutation Test from Roche Molecular Systems is a CE-marked TaqMelt ™ real-time PCR assay intended for the detection of 19 mutations in codons 12, 13 and 61 of the KRAS gene The assay uses DNA extracted from FFPE tissue and is validated for use with the cobas ® 4800 System
  • KRAS Testing - PubMed Central (PMC)
    Single-Strand Conformation Polymorphism (SSCP) and Denaturing Gradient Gel Electrophoresis (DGGE) for KRAS Testing SSCP and DGGE are less often employed for KRAS testing than other methods For both techniques, DNA surrounding the KRAS point mutations is PCR amplified before analysis
  • KRAS - Know Your Biomarker
    How is the KRAS biomarker tested? The recommended method of testing KRAS is with a tumor biopsy sample, either from the primary colorectal adenocarcinoma tumor or from a metastatic tumor KRAS may also be tested in a blood sample by examining circulating tumor DNA (ctDNA) for KRAS mutations This is called a liquid biopsy
  • KRAS Mutation - Testing. com
    This test detects specific mutations in the KRAS gene in the DNA of cancer cells and tissue The presence of these mutations may indicate that certain drugs will not be effective in treating the cancer
  • cobas 4800 KRAS Mutation Test - Food and Drug Administration
    The cobas® KRAS Mutation Test, for use with the cobas® 4800 System, is a real-time PCR test for the detection of seven somatic mutations in codons 12 and 13 of the KRAS gene in DNA derived from
  • KRAS mutation testing in clinical practice - PubMed
    Therapeutically, KRAS mutation testing has maximum utility in stratifying metastatic colorectal carcinoma and lung cancer patients for treatment with targeted therapy Diagnostically, KRAS mutation testing is useful in the workup of pancreaticobiliary and thyroid cancers, particularly using cytological specimens
  • Protocol guide: KRAS variant identification - Thermo Fisher Scientific
    Accurate KRAS characterization depends on Sanger sequencing due to its ability to accurately detect single or multiple mutations Unlike other methods Sanger sequencing also allows identification and detection of novel mutations It is the gold standard for mutation detection
  • Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by . . .
    Genomic DNA of the KRAS mutant sample 81K (G12D Ht) was mixed with wild type DNA of sample 75K in dilutions containing 50%, 25%, 10%, 5%, 2 5% and 0% mutant alleles Moreover, decreasing amounts of template DNA were used to investigate the limits of KRAS mutation detection
  • Diagnostic accuracy of circulating free DNA testing for the detection . . .
    These results provide evidence that detection of KRAS mutation using cfDNA testing is of adequate diagnostic accuracy thus offering to the clinicians a new promising screening test for NSCLC patients
  • KRAS Cancer Basics – Kras Kickers
    In the case of KRAS-driven cancers, KRAS mutation testing aims to provide you with the best treatment plan for your unique needs There are two ways to detect KRAS mutations Next-generation sequencing (NGS) is commonly used to study tumor tissue (gathered from a biopsy)





中文字典-英文字典  2005-2009